Pulse therapy and its modifications in pemphigus: a six year study.

dc.contributor.authorRao, P Nen_US
dc.contributor.authorLakshmi, T Sen_US
dc.date.accessioned2009-05-28T08:03:52Z
dc.date.available2009-05-28T08:03:52Z
dc.date.issued2003-09-24en_US
dc.description.abstractBACKGROUND: Dexamethasone-cyclophosphamide pulse (DCP) therapy for the pemphigus group of disorders is being widely used in India after its introduction in 1986. However, there are certain limitations to its application due to the serious side effects of cyclophosphamide. METHODS: Between 1995 and 2001, we treated 41 patients of pemphigus with modified pulse therapy. These modifications included certain changes in the DCP therapy protocol and substitution of cyclophosphamide with either azathioprine or methotrexate in a few patients. RESULTS: We observed a good response to pulse therapy in all 34 patients who took treatment regularly. CONCLUSIONS: We found the modifications to the original DCP therapy protocol to be very effective and useful.en_US
dc.description.affiliationDepartment of Dermatology, Osmania Medical College, Hyderabad.en_US
dc.identifier.citationRao PN, Lakshmi TS. Pulse therapy and its modifications in pemphigus: a six year study. Indian Journal of Dermatology, Venereology and Leprology. 2003 Sep-Oct; 69(5): 329-33en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/52054
dc.language.isoengen_US
dc.source.urihttps://www.ijdvl.comen_US
dc.titlePulse therapy and its modifications in pemphigus: a six year study.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: